KORU Medical Systems, Inc. - Common Stock (KRMD)

CUSIP: 759910102

Q2 2023 13F Holders as of 30 Jun 2023

Holder snapshot 7 signals
Share change
+1,062,096
Put/Call ratio
32%
SEC-reported price per share
$3.45
Number of holders
62
Value change
+$4,392,355
Number of buys
39
Open additional details 1 more signal available
Number of sells
17
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
45,995,732

Security key

759910102

Report period

Q2 2023

Institutions

62

Top holders

10

Ownership snapshot

Top reported holders of KRMD - KORU Medical Systems, Inc. - Common Stock (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
First Light Asset Managem...
Disclosed value leader
First Light Asset Managem...
Comparable rows
0/15
Latest evidence
31 Mar 2023
13F 3/4/5 Highest disclosed value: $26,127,358 15 rows are not safely comparable across share classes. Showing 1-6 of 15 holder rows.

Quick read

First Light Asset Management, LLC has the largest disclosed position value at $26.13M.

0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens First Light Asset Management, LLC's linked filing trail.
Disclosed position value Top 5
First Light Asset Management, LLC $26.13M
Archon Capital Management LLC $12.53M
VANGUARD GROUP INC $7.15M
Kathy Frommer $4.11M
Parkman Healthcare Partners LLC $3.59M

Value bars compare disclosed positions; verify each figure against the linked filing evidence.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
First Light Asset Management, LLC
13F
Company
13F
—
denominator unverified
$26,127,358
6,191,317 shares
— 31 Mar 2023
Archon Capital Management LLC
13F
Company
13F
—
denominator unverified
$12,532,269
2,969,732 shares
— 31 Mar 2023
VANGUARD GROUP INC
13F
Company
13F
—
denominator unverified
$7,145,903
1,693,342 shares
— 31 Mar 2023
Kathy Frommer
3/4/5
Director
—
denominator unverified
$4,112,279
1,735,139 shares
— 31 Mar 2022
Parkman Healthcare Partners LLC
13F
Company
13F
—
denominator unverified
$3,592,803
851,375 shares
— 31 Mar 2023
ALBION FINANCIAL GROUP /UT
13F
Company
13F
—
denominator unverified
$3,483,024
825,361 shares
— 31 Mar 2023
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q2 2023

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
62
Shares
18,409,479
Rows available
62
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q2 2023 vs Q3 2025 Across Filers

Q3 2025 holders
76
Q2 2023 holders
62
Holder diff
-14
Investor Q3 2025 Shares Q2 2023 Shares Share Diff Share Chg % Q3 2025 value Q2 2023 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .